| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/11/2004 | CN1161152C Method and composition useful for inhibition of angiogenesis |
| 08/11/2004 | CN1161151C Usage of hypophloeodal colyone and its application |
| 08/11/2004 | CN1161150C Pharmaceutical compositions |
| 08/11/2004 | CN1161149C Cytokine and hemopoietic factor endogenous production enhancer and method of use thereof |
| 08/11/2004 | CN1161110C Oral delayed immediate release formulation and method of preparation therefor |
| 08/11/2004 | CN1161107C Oral formulation for gastrointestinal drug delivery |
| 08/10/2004 | US6774259 Condensation of alanine with alkyl butyrate; hydrogenation using palladium-on-carbon catalyst in water and sodium hydroxide; precipitation, filtration; recrystallization from acetonitrile; purification |
| 08/10/2004 | US6774227 Reating disorders related to cellular overproliferation comprising neutralizing the production or activity of macrophage migration inhibitory factor (mif) |
| 08/10/2004 | US6774224 ULBP DNA and polypeptides |
| 08/10/2004 | US6774220 Compounds having lectinic properties and their biological applications |
| 08/10/2004 | US6774219 Candida albicans gene, integrin-like protein, antibodies, and methods of use |
| 08/10/2004 | US6774218 Drugs, vaccines |
| 08/10/2004 | US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation |
| 08/10/2004 | US6774216 Antibody for use in diagnosis and treatment of immunological, inflammatory and nervous system disorders |
| 08/10/2004 | US6774212 For therapy of viral infection or as an assay standard or reagent |
| 08/10/2004 | US6774128 Administering to the mammal a therapeutically effective amount of a compound that increases nitric oxide (no) activity as measured in a standard gastric emptying assay |
| 08/10/2004 | US6774120 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 08/10/2004 | US6774118 Therapeutic use of CIS-element decoys in vivo |
| 08/10/2004 | US6774117 MN gene and protein |
| 08/10/2004 | US6774116 Prodrugs via acylation with cinnamate |
| 08/10/2004 | US6774109 Inhibition of amylin release |
| 08/10/2004 | US6774108 Administering to mammal a therapeutically effective amount of recombinant human alpha-fetoprotein or a fragment thereof for inhibiting transplant rejection |
| 08/10/2004 | US6774107 Protein for blocking platelet adhesion |
| 08/10/2004 | US6774106 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
| 08/10/2004 | US6774105 Methods of using latent TGF-β binding proteins |
| 08/10/2004 | US6774104 Cyclic polypeptide stabilized with lactose |
| 08/10/2004 | US6773912 Lantibiotic |
| 08/10/2004 | US6773911 Homologous recombination |
| 08/10/2004 | US6773908 From open reading frames; vaccines |
| 08/10/2004 | US6773904 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 08/10/2004 | US6773897 Monitoring response of cells to antitumor agents; obbtain cells, recover nucleotide sequences, incubate with antitumor agent, monitor methylation of nucleotide sequences compare to control |
| 08/10/2004 | US6773886 Binary encoded sequence tags |
| 08/10/2004 | US6773881 By modulating vascular endothelial growth factor (vegf) |
| 08/10/2004 | US6773878 For therapy/drug screening |
| 08/10/2004 | US6773723 Collagen/polysaccharide bilayer matrix |
| 08/10/2004 | US6773714 Polymeric delivery formulations of leuprolide with improved efficacy |
| 08/10/2004 | US6773711 Botulinum toxin therapy for Hashimoto's thyroiditis |
| 08/10/2004 | US6773707 Employing hybrid antigen complex |
| 08/10/2004 | US6773706 Enzymatic polypeptide for use in the diagnosis and treatment of bacterial infections |
| 08/10/2004 | US6773705 Restoring nf kappa b activity |
| 08/10/2004 | US6773704 Methods of treating vascular disease associated with cystatin C deficiency |
| 08/10/2004 | US6773703 Connected to polyethylene glycol via urea groups; healing therapy resistant wounds |
| 08/10/2004 | US6773702 Treating immune suppression in a warm-blooded animal bearing a tumor; immunotherapy |
| 08/10/2004 | US6773701 Expression enhancer for protein synthesis inhibitory genes |
| 08/10/2004 | US6773414 Device and method for dispensing at least two mutually reactive components |
| 08/10/2004 | CA2315266C Wound healing compositions |
| 08/10/2004 | CA2260365C Differentiation-suppressive polypeptide |
| 08/10/2004 | CA2255661C Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 08/10/2004 | CA2234899C Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist, method for preparation and use thereof in the treatment of cardiovascularillnesses |
| 08/10/2004 | CA2145501C Method for treatment or prevention of obesity |
| 08/10/2004 | CA2121041C Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
| 08/09/2004 | WO2004065591A1 Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals |
| 08/07/2004 | CA2457220A1 Inhibitors of staphylococcus aureus primary sigma factor and uses thereof |
| 08/07/2004 | CA2457105A1 Pharmaceutical preparation for the improved treatment of blood-clotting disorders |
| 08/05/2004 | WO2004065621A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 08/05/2004 | WO2004065613A2 Inducible small interfering rna (sirna) expression constructs for targeted gene silencing |
| 08/05/2004 | WO2004065601A2 Lipophilic derivatives of double-stranded ribonucleic acid |
| 08/05/2004 | WO2004065600A2 Rna interference by palindromic or modified rna molecules |
| 08/05/2004 | WO2004065592A2 The crystal structure of a catalytically active portion of a set 7/9 histone methyltransferase and uses thereof |
| 08/05/2004 | WO2004065572A2 Proteic binding partners of tctp and methods of modulating tumor reversion or cell apoptosis |
| 08/05/2004 | WO2004065547A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 08/05/2004 | WO2004065546A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ICAM-1 |
| 08/05/2004 | WO2004065540A2 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 08/05/2004 | WO2004065538A2 Protein domain related to deafness, osteoarthritis and abnormal cell proliferation |
| 08/05/2004 | WO2004065414A1 Process for the preparation of hypoallergenic mosaic antigens |
| 08/05/2004 | WO2004065413A1 Novel substances k01-b0171 and process for producing the same |
| 08/05/2004 | WO2004065411A2 Peptides |
| 08/05/2004 | WO2004065410A2 Mntf peptides and compositions and methods of use |
| 08/05/2004 | WO2004065406A2 Rantes-derived peptides with anti-hiv activity |
| 08/05/2004 | WO2004064866A1 Combined use of carnosinase inhibitor with l-carnosines and composition |
| 08/05/2004 | WO2004064862A1 Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes |
| 08/05/2004 | WO2004064861A1 Nerve cell death inhibitor |
| 08/05/2004 | WO2004064860A1 Use of tff2, or agents inducing tff2, in the therapy of allergies |
| 08/05/2004 | WO2004064859A1 A hybrid vector system for use as a vaccine |
| 08/05/2004 | WO2004064858A1 Drug containing human arterial natriuretic peptide |
| 08/05/2004 | WO2004064857A1 Drugs containing galectin 9 |
| 08/05/2004 | WO2004064856A2 Proteins involved in the regulation of energy homeostasis |
| 08/05/2004 | WO2004064855A1 Medicament and use thereof for tumor therapy |
| 08/05/2004 | WO2004064854A1 Method for enhancing learning and memory by suppressing the activity of ncx2 protein |
| 08/05/2004 | WO2004064849A1 Means for normalising structure and functions of organs and tissues, stimulating injury recovery and exhibiting antiviral activity |
| 08/05/2004 | WO2004064844A1 Method for inhibition of necrosis induced by neurotrophin |
| 08/05/2004 | WO2004064839A1 Salts of codrugs of an opioid together with a second active moiety and uses thereto |
| 08/05/2004 | WO2004064822A1 Method of inhibiting prostate cancer cell proliferation |
| 08/05/2004 | WO2004064788A2 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 08/05/2004 | WO2004064787A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 08/05/2004 | WO2004064786A2 Article for debridement and detoxification of wounds |
| 08/05/2004 | WO2004064785A2 Cancer therapy sensitizer |
| 08/05/2004 | WO2004064780A2 Peptide-based angiogenesis inhibitors and methods of use thereof |
| 08/05/2004 | WO2004064767A2 Nitric oxide inducing agents |
| 08/05/2004 | WO2004064766A2 Method of treatment of conditions by administration of streptolysin o |
| 08/05/2004 | WO2004064763A2 Cleavage of serum response factor in cardiac diagnosis and therapy |
| 08/05/2004 | WO2004064759A2 Use of tryptanthrin compounds for immune potentiation |
| 08/05/2004 | WO2004064758A2 Improved oral delivery of peptides |
| 08/05/2004 | WO2004064755A2 Methods for inhibiting proteasome |
| 08/05/2004 | WO2004064750A2 Improved constructs for expressing lysosomal polypeptides |
| 08/05/2004 | WO2004064740A2 Sperm specific lysozyme-like proteins |
| 08/05/2004 | WO2004064732A2 The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl |
| 08/05/2004 | WO2004064727A2 Method of cancer treatment using hdac inhibitors |
| 08/05/2004 | WO2004064717A2 Cop 1 for treatment of inflammatory bowel diseases |
| 08/05/2004 | WO2004064713A2 The use of yop preoteins or rho gtpase inhibitors as caspase-1 inhibitors |